Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs M&T Bank Corporation (MTB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs M&T Bank Corporation — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while M&T Bank Corporation trades at $215.86 (market cap $31.20B). The key difference: M&T Bank Corporation is far larger — about 3.5× Kymera Therapeutics Inc. Common Stock's market cap, and M&T Bank Corporation pays a 2.78% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and M&T Bank Corporation for 99 Days on average.
| KYMR | MTB | |
|---|---|---|
Market Cap | $8.88B | $31.20B |
Volume | 1,028,790 | 795,459 |
Sector | Health | Financials |
52-Week High | $127.31 | $254.09 |
52-Week Low | $55.80 | $178.63 |
Typical Hold Time | 0 Days | 99 Days |
Enterprise Value | $8.27B | $47.44B |
Dividend Yield | — | 2.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
M&T Bank (MTB) trades at $217.93, down 0.89% on the day, with a bearish technical signal and neutral oscillators. The stock shows strong fundamentals with a P/E of 11.54, net income margin of 30.85%, and three consecutive quarterly EPS beats. Recent news highlights loan growth, AI investments, and a new branch opening, while the company maintains a consistent dividend.
Outlook is cautiously optimistic given solid profitability and analyst consensus, but risks include negative net cash flow trends and elevated debt levels. The consensus price target of $256.62 suggests potential upside, contingent on continued earnings momentum and stable interest rate environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About M&T Bank Corporation
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →
